Glaucoma implant material may influence IOP

Article

A study in the September/October issue of the European Journal of Ophthalmology has shown that the silicone plate Ahmed glaucoma valve (AGV) results in lower intraocular pressure (IOP) compared with the older polypropylene plate AGV.

A study in the September/October issue of the European Journal of Ophthalmology has shown that the silicone plate Ahmed glaucoma valve (AGV) results in lower intraocular pressure (IOP) compared with the older polypropylene plate AGV.

David Miguel Hinkle and colleagues from Tulane University Health Sciences Center and Harvard Medical School, US, reviewed 25 eyes of 22 patients undergoing silicone plate AGV (FP-7) and 26 eyes of 22 patients undergoing polypropylene plate AGV (S-2) implantation.

After implantation, IOP reductions were recorded in both the FP-7 group (29.6±13.1 to 12.1±3.4 mm Hg) and the S-2 group (31.4±11.7 to 16.1±5.7 mmHg). However, the FP-7 group had a statistically lower IOP compared with the S-2 group at six and 12 months.

Based on these results, it was concluded that plate material might influence clinical outcomes.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.